Drug target validation

The majority of drugs that fail to complete the development process do so due to lack of efficacy; indicating that the wrong target was pursued. This spotlight will aim to review the challenges in accurate and efficient drug target validation. We will also cover recent developments in methods and techniques as well as commenting on notable new therapeutic targets identified in recent years.